Mishustin signed a decree on the import of the drug "Oncaspar"

This is stated in a message on the government website.

“The medicine is produced in France and has no domestic analogues. In April 2020, it was decided to import 1.5 thousand packages of the drug. The government has allocated more than 273.5 million rubles for this purpose, ”the document says.

As specified, the purchase, import and delivery of the drug is handled by the Moscow Endocrine Plant.